InspireMD Inc. (NSPR)

Jun 15, 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com

Jun 15, 2026

Jun 15, 2026

InspireMD announces inducement grants - Medical Buyer

Jun 15, 2026

Jun 12, 2026

NSPR Q1 2026 Earnings: EPS Beat Surprises on Strong Cost ManagementCore Business Growth - newsline.com

Jun 12, 2026

Jun 12, 2026

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 12, 2026

Jun 12, 2026

Six new InspireMD employees receive 91,161-share stock grants - Stock Titan

Jun 12, 2026

Jun 11, 2026

InspireMD, Inc. (NSPR) reports Q1 loss, tops revenue estimates - MSN

Jun 11, 2026

Jun 11, 2026

InspireMD Reports Strong 30-Day Results From CGUARDIANS II Trial - TipRanks

Jun 11, 2026

Jun 11, 2026

Stroke-prevention stent hits 100% success in 50 high-risk patients - Stock Titan

Jun 11, 2026

Jun 11, 2026

InspireMD (NSPR) reports 100% device success in TCAR trial - Stock Titan

Jun 11, 2026

Jun 11, 2026

InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures - marketscreener.com

Jun 11, 2026

Jun 10, 2026

NSPR Technical Analysis | Trend, Signals & Chart Patterns - ChartMill

Jun 10, 2026

Jun 08, 2026

NSPR Q1 2026 Earnings: EPS Surprises to the Upside Amid Limited Revenue VisibilityPost-Earnings Drift - newsline.com

Jun 08, 2026

Jun 08, 2026

InspireMD Initiates CGUARDIANS III Study for SwitchGuard Neuro Protection System in TCAR Procedures - Quiver Quantitative

Jun 08, 2026

Jun 08, 2026

InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures - GlobeNewswire

Jun 08, 2026

Jun 05, 2026

NSPR Q1 2026 Earnings: EPS Surprise of 12.85% Highlights Cost Discipline Amid Pre‑Revenue Stage - newsline.com

Jun 05, 2026

Jun 05, 2026

NSPR News | INSPIREMD INC (NASDAQ:NSPR) - ChartMill

Jun 05, 2026

Jun 03, 2026

InspireMD (NSPR) holders OK 250M authorized shares, re-elect directors - Stock Titan

Jun 03, 2026

Jun 01, 2026

InspireMD NSPR Q1 2026 Earnings Transcript - The Globe and Mail

Jun 01, 2026

May 30, 2026

NSPR Q1 2026 Earnings: EPS Surprises to the Upside, Stock Reacts PositivelyEstimate Revision Count - thelegaladvocate.com

May 30, 2026

May 30, 2026

InspireMD director Paul Stuka buys $17,500 in shares By Investing.com - Investing.com Australia

May 30, 2026

May 29, 2026

InspireMD (NSPR) Inches Higher as Shares Approach Key Resistance at $0.97Gap and Go - thelegaladvocate.com

May 29, 2026

May 29, 2026

InspireMD director Paul Stuka buys $17,500 in shares - Investing.com

May 29, 2026

May 29, 2026

Director Paul Stuka buys 20,000 InspireMD (NSPR) shares in open-market trade - Stock Titan

May 29, 2026

May 29, 2026

InspireMD (NSPR) Gains 6% to $0.95 as Stock Approaches Critical $1.00 ResistanceHigh Conviction Picks - newsline.com

May 29, 2026

May 28, 2026

InspireMD anticipates FDA approval of original CGuard delivery system in Q3 2026 as it withdraws 2026 revenue guidance - MSN

May 28, 2026

May 28, 2026

InspireMD Inc. (NSPR) Q1 2026 Earnings: Narrower Loss Than Expected But Shares SlideEarnings Call Highlights - thelegaladvocate.com

May 28, 2026

May 27, 2026

InspireMD (NSPR) Slides 7.9% as Stock Tests Key Support Near $0.84RVOL Spike - The Legal Advocate

May 27, 2026

May 27, 2026

InspireMD (NSPR) Slides 8.4% to $0.87: Key Levels Under PressureEarnings Beat Stocks - newsline.com

May 27, 2026

May 23, 2026

InspireMD (NSPR) Q1 2026 Earnings: EPS Beat Despite Net Loss, Shares Dip 2.9%Post-Announcement Reaction - Newser

May 23, 2026

May 22, 2026

Paul Stuka to Retire from InspireMD Board, Will Not Seek Re‑election - TradingView

May 22, 2026

May 22, 2026

InspireMD (NSPR) chair Paul Stuka plans Board retirement in 2027 - Stock Titan

May 22, 2026

May 22, 2026

NSPR Q1 2026 Earnings: Loss Narrower Than Expected as InspireMD Advances Commercial PipelineProfit Growth Outlook - Newser

May 22, 2026

May 21, 2026

InspireMD CCO Shane Gleason sells $189,594 in stock By Investing.com - Investing.com Canada

May 21, 2026

May 21, 2026

InspireMD CCO Shane Gleason sells $189,594 in stock - Investing.com

May 21, 2026

May 21, 2026

InspireMD (NSPR) CCO auto-sells shares to cover RSU tax obligations - Stock Titan

May 21, 2026

May 17, 2026

InspireMD (NSPR) price target decreased by 13.33% to 4.42 - MSN

May 17, 2026

May 15, 2026

Nantahala reports 4.82M shares in InspireMD (NSPR) including convertibles - Stock Titan

May 15, 2026

May 15, 2026

Director Stuka increases InspireMD (NSPR) stake with 15,000-share buys - Stock Titan

May 15, 2026

May 15, 2026

Velan Capital holds 4.99% of InspireMD (NASDAQ: NSPR) via 2.35M shares - Stock Titan

May 15, 2026

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 14, 2026

InspireMD CEO Marvin Slosman buys $25,200 in company stock By Investing.com - Investing.com Australia

May 14, 2026

May 13, 2026

InspireMD Inc (NSPR) CEO Marvin Slosman Increases Stake with Rec - GuruFocus

May 13, 2026

May 13, 2026

NSPR: Endovascular stenting for carotid disease is accelerating, backed by best-in-class clinical results - TradingView

May 13, 2026

May 13, 2026

InspireMD CEO Marvin Slosman buys $25,200 in company stock - Investing.com UK

May 13, 2026